P971: ADJUSTED COMPARISON OF PATIENT REPORTED OUTCOMES FROM CARTITUDE-1 AND LOCOMMOTION COMPARING CILTACABTAGENE AUTOLEUCEL VERSUS REAL WORLD CLINICAL PRACTICE IN TRIPLE-CLASS EXPOSED MULTIPLE MYELOMA

• K. Weisel,
• M.-V. Mateos,
• L. Vincent,
• T. Martin,
• J. G. Berdeja,
• A. Jakubowiak,
• S. Jagannath,
• Y. Lin,
• P. Thilakarathne,
• F. Ghilotti,
• J. Diels,
• B. Haefliger,
• C. Hague,
• A. Gonzalez,
• J. M. Schecter,
• K. S. Gries,
• V. Strulev,
• T. Nesheiwat,
• L. Pacaud,
• H. Einsele,
• P. Moreau

Affiliations

K. Weisel

1 Oncology, Hematology and BMT, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany

M.-V. Mateos

2 CIC, University Hospital of Salamanca/IBSAL, Salamanca, Spain

L. Vincent

3 Clinical Haematology Department, Montpellier University Hospital, Montpellier, France

T. Martin

4 UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

J. G. Berdeja

5 Sarah Cannon Research Institute, Nashville

A. Jakubowiak

6 University of Chicago, Chicago

S. Jagannath

7 Mount Sinai Medical Center, New York

Y. Lin

8 Mayo Clinic, Rochester, United States of America

P. Thilakarathne

9 Health Economics, Market Access & Reimbursement, Janssen Pharmaceutica NV, Beerse, Belgium

F. Ghilotti

10 Health Economics, Market Access & Reimbursement, Janssen-Cilag SpA, Cologno Monzese, Italy

J. Diels

9 Health Economics, Market Access & Reimbursement, Janssen Pharmaceutica NV, Beerse, Belgium

B. Haefliger

11 Health Economics, Market Access & Reimbursement, Cilag GmbH International, Zug, Switzerland

C. Hague

12 Health Economics, Market Access & Reimbursement, Janssen, High Wycomb, United Kingdom

A. Gonzalez

11 Health Economics, Market Access & Reimbursement, Cilag GmbH International, Zug, Switzerland

J. M. Schecter

13 Research and Development, Janssen R&D, Raritan

K. S. Gries

14 Research and Development, Janssen R&D, Los Angeles, United States of America

V. Strulev

15 EMEA Medical Affairs, Janssen Pharmaceutica NV, Beerse, Belgium

T. Nesheiwat

16 Legend Biotech USA, Piscataway, United States of America

L. Pacaud

16 Legend Biotech USA, Piscataway, United States of America

H. Einsele

17 Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany

P. Moreau

18 Clinical Hematology, University Hospital Hotel-Dieu, Nantes, France